These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

985 related items for PubMed ID: 18202141

  • 1. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
    Chu ZL, Carroll C, Alfonso J, Gutierrez V, He H, Lucman A, Pedraza M, Mondala H, Gao H, Bagnol D, Chen R, Jones RM, Behan DP, Leonard J.
    Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
    [Abstract] [Full Text] [Related]

  • 2. GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms.
    Flock G, Holland D, Seino Y, Drucker DJ.
    Endocrinology; 2011 Feb; 152(2):374-83. PubMed ID: 21068156
    [Abstract] [Full Text] [Related]

  • 3. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.
    Chu ZL, Jones RM, He H, Carroll C, Gutierrez V, Lucman A, Moloney M, Gao H, Mondala H, Bagnol D, Unett D, Liang Y, Demarest K, Semple G, Behan DP, Leonard J.
    Endocrinology; 2007 Jun; 148(6):2601-9. PubMed ID: 17289847
    [Abstract] [Full Text] [Related]

  • 4. Novel GPR119 agonist HD0471042 attenuated type 2 diabetes mellitus.
    Ha TY, Kim YS, Kim CH, Choi HS, Yang J, Park SH, Kim DH, Rhee JK.
    Arch Pharm Res; 2014 May; 37(5):671-8. PubMed ID: 23897163
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. β-Cell Inactivation of Gpr119 Unmasks Incretin Dependence of GPR119-Mediated Glucoregulation.
    Panaro BL, Flock GB, Campbell JE, Beaudry JL, Cao X, Drucker DJ.
    Diabetes; 2017 Jun; 66(6):1626-1635. PubMed ID: 28254842
    [Abstract] [Full Text] [Related]

  • 7. 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans.
    Hansen KB, Rosenkilde MM, Knop FK, Wellner N, Diep TA, Rehfeld JF, Andersen UB, Holst JJ, Hansen HS.
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1409-17. PubMed ID: 21778222
    [Abstract] [Full Text] [Related]

  • 8. Chylomicrons stimulate incretin secretion in mouse and human cells.
    Psichas A, Larraufie PF, Goldspink DA, Gribble FM, Reimann F.
    Diabetologia; 2017 Dec; 60(12):2475-2485. PubMed ID: 28866808
    [Abstract] [Full Text] [Related]

  • 9. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.
    Lan H, Lin HV, Wang CF, Wright MJ, Xu S, Kang L, Juhl K, Hedrick JA, Kowalski TJ.
    Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751
    [Abstract] [Full Text] [Related]

  • 10. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
    Chang E, Kim L, Choi JM, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park DI, Park CY.
    Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oral 2-oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor.
    Hassing HA, Engelstoft MS, Sichlau RM, Madsen AN, Rehfeld JF, Pedersen J, Jones RM, Holst JJ, Schwartz TW, Rosenkilde MM, Hansen HS.
    Biofactors; 2016 Nov 12; 42(6):665-673. PubMed ID: 27297962
    [Abstract] [Full Text] [Related]

  • 13. Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.
    Sangle GV, Lauffer LM, Grieco A, Trivedi S, Iakoubov R, Brubaker PL.
    Endocrinology; 2012 Feb 12; 153(2):564-73. PubMed ID: 22186413
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD, Gault VA, O'Harte FP, Flatt PR.
    Diabetes Obes Metab; 2005 Sep 12; 7(5):595-604. PubMed ID: 16050953
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Physiological and pharmacological mechanisms through which the DPP-4 inhibitor sitagliptin regulates glycemia in mice.
    Waget A, Cabou C, Masseboeuf M, Cattan P, Armanet M, Karaca M, Castel J, Garret C, Payros G, Maida A, Sulpice T, Holst JJ, Drucker DJ, Magnan C, Burcelin R.
    Endocrinology; 2011 Aug 12; 152(8):3018-29. PubMed ID: 21673098
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.